Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
Clozapine has been consistently shown to be superior to other antipsychotics in the treatment of psychosis. However, clozapine usage has been limited due to required routine blood monitoring and the potential for life threatening side effects. We report a case of a 66-year-old female patient, who de...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Case Reports in Psychiatry |
Online Access: | http://dx.doi.org/10.1155/2016/6123913 |
id |
doaj-f404443a460d4882941e3ec209644e09 |
---|---|
record_format |
Article |
spelling |
doaj-f404443a460d4882941e3ec209644e092020-11-24T20:44:47ZengHindawi LimitedCase Reports in Psychiatry2090-682X2090-68382016-01-01201610.1155/2016/61239136123913Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine ResponseLila Aboueid0Richard H. McCarthy1SUNY Downstate Medical Center, Department of Psychiatry, 450 Clarkson Avenue, Brooklyn, NY 11203, USAKingsboro Psychiatric Center, 681 Clarkson Avenue, Brooklyn, NY 11203, USAClozapine has been consistently shown to be superior to other antipsychotics in the treatment of psychosis. However, clozapine usage has been limited due to required routine blood monitoring and the potential for life threatening side effects. We report a case of a 66-year-old female patient, who developed clozapine-induced agranulocytosis after 10 weeks of clozapine treatment and was subsequently successfully treated with a combination of loxapine and cyproheptadine. The combination is thought to mimic the pharmacological profile of clozapine, rendering it as a possible alternative to traditional clozapine treatment.http://dx.doi.org/10.1155/2016/6123913 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lila Aboueid Richard H. McCarthy |
spellingShingle |
Lila Aboueid Richard H. McCarthy Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response Case Reports in Psychiatry |
author_facet |
Lila Aboueid Richard H. McCarthy |
author_sort |
Lila Aboueid |
title |
Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response |
title_short |
Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response |
title_full |
Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response |
title_fullStr |
Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response |
title_full_unstemmed |
Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response |
title_sort |
loxapine and cyproheptadine combined limit clozapine rebound psychosis and may also predict clozapine response |
publisher |
Hindawi Limited |
series |
Case Reports in Psychiatry |
issn |
2090-682X 2090-6838 |
publishDate |
2016-01-01 |
description |
Clozapine has been consistently shown to be superior to other antipsychotics in the treatment of psychosis. However, clozapine usage has been limited due to required routine blood monitoring and the potential for life threatening side effects. We report a case of a 66-year-old female patient, who developed clozapine-induced agranulocytosis after 10 weeks of clozapine treatment and was subsequently successfully treated with a combination of loxapine and cyproheptadine. The combination is thought to mimic the pharmacological profile of clozapine, rendering it as a possible alternative to traditional clozapine treatment. |
url |
http://dx.doi.org/10.1155/2016/6123913 |
work_keys_str_mv |
AT lilaaboueid loxapineandcyproheptadinecombinedlimitclozapinereboundpsychosisandmayalsopredictclozapineresponse AT richardhmccarthy loxapineandcyproheptadinecombinedlimitclozapinereboundpsychosisandmayalsopredictclozapineresponse |
_version_ |
1716816642723282944 |